Based on my experience across diverse industries, I’ve found that resilient cybersecurity architecture begins with a strong ...

Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2.

CirrusSync is a secure, cross-platform cloud storage application that prioritizes user privacy through end-to-end encryption. Built with Tauri, it combines the performance of Rust with the flexibility ...